The twin epidemics of TB and COVID-19: challenges and controversies
11th August 2020
Trial of potential Covid-19 treatment begins in SA
27th August 2020
Eyewitness News – Mia Lindeque | 14 August 2020
Dr Gray said that before the end of August, a second vaccine trial would be rolled out followed by a third in September.
SAMRC CEO Professor Glenda Gray (R) was screened and vaccinated at UCT’s Lung Institute on 11 August 2020, as part of a a COVID-19 vaccine study. Picture: Kevin Brandt/EWN
- Coronavirus
- Coronavirus in South Africa
- COVID-19 vaccine
JOHANNESBURG – CEO of the South African Medical Research Council (SAMRC), Professor Glenda Gray, on Thursday said that with more vaccine trials being rolled out in the country, it increased the chances of some turning out to be successful.
Dr Gray said that before the end of August, a second vaccine trial would be rolled out followed by a third in September.
She said, however, that if more than one vaccine turned out successful, it would be made more affordable to the public.
https://ewn.co.za/2020/08/13/the-more-vaccines-that-work-the-more-affordable-they-ll-be-prof-glenda-gray
